Humana Inc (HUM) stock
Close on Nov 12, 2026Market cap $53.28BP/E 43.0Yield 0.80%
Humana Inc grew revenue 22.0% to $154.19B over the twelve months to Sep 30, 2026. Operating income fell 19.8% to $2.38B, moving the operating margin from 2.3% to 1.5%. Free cash flow was $3.14B, up 102.9% from a year earlier. At the latest close the market valued the company at $53.28B, 43.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $53.28B
- P/E ratio
- 43.0
- Price to sales
- 0.35
- Price to book
- 2.83
- Dividend yield
- 0.80%
- Free cash flow yield
- 5.89%
Fundamentals
- Revenue
- $154.19B
- Net income
- $1.25B
- EPS, diluted
- $10.31
- Free cash flow
- $3.14B
- Book value per share
- $154.52
- Diluted shares
- 122M
Trading
- Next earnings
- Feb 10, 2027 (estimated, before the open)
- Previous close
- $446.31
- Open
- $450.00
- Day's range
- $434.09 – $450.00
- Volume
- 1,936,062
- Average volume (20 days)
- 1,566,552
- Index membership
- S&P 500, Russell 1000, Russell 3000
- Beta (5 years)
- 0.45
- 52-week range
- $163.11 – $456.50
- RSI (14 days)
- 63.8
- Volatility (1 year)
- 46.0%
- Relative volume
- 1.85×
- WACC
- 6.8%
On 1 of our idea list: New highs on volume
Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | HUM | S&P 500 | Difference | HUM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +2.3% | -2.7% | +5.0 pts | ||
| 3 months | +14.1% | -1.7% | +15.9 pts | ||
| Year to date | +74.5% | +11.9% | +62.6 pts | ||
| 1 year | +86.5% | +12.0% | +74.5 pts | ||
| 3 years | -6.9% | +78.2% | −85.0 pts | -2.3% | +21.2% |
| 5 years | +4.5% | +73.2% | −68.7 pts | +0.9% | +11.6% |
| 10 years | +149.5% | +309.6% | −160.1 pts | +9.6% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Humana filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Results
- Results
- Update
- Results
About Humana
Hospital & Medical Service Plans
Humana Inc. provides health insurance and healthcare delivery services across two primary operating divisions: Insurance and CenterWell. The Insurance segment offers Medicare Advantage, Medicare Supplement, stand-alone prescription drug plans, and Medicaid coverage, alongside specialty benefits such as dental, vision, life, and disability plans. It also delivers pharmacy benefit management and administrative services for military healthcare programs. CenterWell operates physician-directed clinical capabilities, including senior-focused primary care clinics, pharmacy solutions spanning mail-order and specialty fulfillment, and in-home health services. The company serves Medicare and Medicaid beneficiaries, individual policyholders, employer groups, and military personnel and their families.
Company profile, executives and historyHumana stock: common questions
What is Humana's stock price?
HUM closed at $443.68 on Nov 12, 2026, down 0.59% on the day. Over the past 52 weeks it traded between $163.11 and $456.50.
What is Humana's market cap?
Humana was worth $53.28B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is HUM's P/E ratio?
HUM trades at 43.0 times earnings, based on diluted earnings per share of $10.31 over the twelve months to Sep 30, 2026.
How much revenue does Humana make?
Humana reported revenue of $154.19B for the twelve months to Sep 30, 2026, up 22.0% from a year earlier.
Does Humana pay a dividend?
Yes. Humana paid $3.54 per share over the last twelve months, a yield of 0.80% at the latest price.
When does Humana report earnings next?
Humana is expected to report Q4 FY2026 results on Feb 10, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has HUM stock performed over the past year?
Including dividends, HUM returned +86.5% over the past year, against +12.0% for the S&P 500.
How many HUM shares are sold short?
3M shares were sold short at the latest FINRA report, 2.32% of the float, or 2.1 days of average trading volume.
Who are Humana's competitors?
Companies most similar to Humana by business, industry and size include CNC, ELV, CI, MOH, UNH.
See a number that looks wrong?